Global Retirement Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $87.8K | Buy |
499
+337
| +208% | +$55.1K | ﹤0.01% | 1990 |
|
|
2025
Q3 | $22.7K | Buy |
162
+60
| +59% | +$8.11K | ﹤0.01% | 2342 |
|
|
2025
Q2 | $12.8K | Buy |
+102
| New | +$12.7K | ﹤0.01% | 2485 |
|
|
2024
Q4 | $17.4K | Sell |
114
-193
| -63% | -$32.6K | ﹤0.01% | 2163 |
|
|
2024
Q3 | $59.5K | Sell |
307
-73
| -19% | -$15.3K | ﹤0.01% | 1484 |
|
|
2024
Q2 | $88.1K | Buy |
380
+207
| +120% | +$45K | ﹤0.01% | 1268 |
|
|
2024
Q1 | $37.3K | Sell |
173
-90
| -34% | -$21.1K | ﹤0.01% | 1535 |
|
|
2023
Q4 | $64.7K | Buy |
263
+107
| +69% | +$26.3K | ﹤0.01% | 1241 |
|
|
2023
Q3 | $40.1K | Buy |
156
+27
| +21% | +$7.22K | ﹤0.01% | 1369 |
|
|
2023
Q2 | $36.7K | Buy |
129
+1
| +0.8% | +$298 | ﹤0.01% | 1419 |
|
|
2023
Q1 | $39.8K | Buy |
128
+58
| +83% | +$16K | ﹤0.01% | 1334 |
|
|
2022
Q4 | $19.4K | Sell |
70
-2
| -3% | -$565 | ﹤0.01% | 1496 |
|
|
2022
Q3 | $20K | Buy |
72
+4
| +6% | +$850 | ﹤0.01% | 1386 |
|
|
2022
Q2 | $14K | Buy |
68
+4
| +6% | +$818 | ﹤0.01% | 1478 |
|
|
2022
Q1 | $13K | Buy |
+64
| New | +$13.9K | ﹤0.01% | 1511 |
|
|
2021
Q4 | – | Sell |
-60
| Closed | -$17K | – | 392 |
|
|
2021
Q3 | $17K | Buy |
60
+14
| +30% | +$4.59K | ﹤0.01% | 1247 |
|
|
2021
Q2 | $16K | Buy |
46
+28
| +156% | +$8.48K | ﹤0.01% | 1245 |
|
|
2021
Q1 | $5K | Hold |
18
| – | – | ﹤0.01% | 1466 |
|
|
2020
Q4 | $4K | Hold |
18
| – | – | ﹤0.01% | 1476 |
|
|
2020
Q3 | $5K | Hold |
18
| – | – | ﹤0.01% | 1305 |
|
|
2020
Q2 | $5K | Sell |
18
-6
| -25% | -$1.8K | ﹤0.01% | 1278 |
|
|
2020
Q1 | $8K | Sell |
24
-45
| -65% | -$13.7K | ﹤0.01% | 1080 |
|
|
2019
Q4 | $20K | Sell |
69
-10
| -13% | -$2.77K | ﹤0.01% | 929 |
|
|
2019
Q3 | $18K | Sell |
79
-82
| -51% | -$19.1K | ﹤0.01% | 929 |
|
|
2019
Q2 | $38K | Sell |
161
-38
| -19% | -$8.77K | 0.01% | 675 |
|
|
2019
Q1 | $47K | Sell |
199
-10
| -5% | -$3.15K | 0.01% | 559 |
|
|
2018
Q4 | $63K | Sell |
209
-6
| -3% | -$1.92K | 0.02% | 466 |
|
|
2018
Q3 | $76K | Buy |
215
+7
| +3% | +$2.41K | 0.02% | 462 |
|
|
2018
Q2 | $60K | Buy |
208
+55
| +36% | +$15.5K | 0.02% | 498 |
|
|
2018
Q1 | $42K | Buy |
153
+89
| +139% | +$27.6K | 0.01% | 571 |
|
|
2017
Q4 | $20K | Sell |
64
-17
| -21% | -$5.45K | 0.01% | 717 |
|
|
2017
Q3 | $25K | Buy |
81
+4
| +5% | +$1.18K | 0.01% | 587 |
|
|
2017
Q2 | $21K | Hold |
77
| – | – | 0.01% | 589 |
|
|
2017
Q1 | $21K | Buy |
77
+6
| +8% | +$1.7K | 0.01% | 537 |
|
|
2016
Q4 | $20K | Buy |
+71
| New | +$21K | 0.01% | 510 |
|
Other funds holding BIIB
Global Retirement Partners's BIIB Position: Q4 2025 in Review
Global Retirement Partners increased its Biogen (BIIB) stake by 208% in Q4 2025, buying an estimated $55.1K and bringing the position to 499 shares worth $87.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.
Global Retirement Partners first reported a position in BIIB in Q4 2016 and has held it in 35 quarters since. The position peaked at $88.1K in Q2 2024. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Global Retirement Partners held 499 shares of Biogen worth $87.8K as of Q4 2025.
- Global Retirement Partners bought 337 Biogen shares in Q4 2025, an estimated $55.1K.
- Biogen made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1990 holding.
- Global Retirement Partners first reported a position in Biogen in Q4 2016 and has held it in 35 quarters since.
- Global Retirement Partners's Biogen position peaked at $88.1K in Q2 2024.
- 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.